Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dehydroepiandrosterone and Abiraterone

Research Papers that Mention the Interaction

Conclusions: We conclude that abi inhibits 3βHSD-mediated conversion of DHEA to active androgens in CRPC.
Clinical Cancer Research  •  2012  |  View Paper
Enzyme kinetic analysis showed that galeterone and abiraterone acetate inhibited human liver cytosolic DHEA sulfonation with apparent Ki values at submicromolar concentrations, whereas cyproterone acetate, spironolactone, and danazol inhibited it with apparent Ki values at low micromolar concentrations.
Drug Metabolism and Disposition  •  2018  |  View Paper
The marked increase of DHEA levels by Abi resembles the steroidogenic pathways in nervous tissue, in a manner that precludes CYP17A1 activity.
The Journal of Steroid Biochemistry and Molecular Biology  •  2017  |  View Paper
Abiraterone had a significant influence on the metabolism of DHEA , epiandrosterone and 3β-diol, by the inhibition of the intratumoural 3β-hydroxysteroid dehydrogenase (3β-HSD) activities which is one of key catalysts in androgen metabolic pathway.
Scientific reports  •  2016  |  View Paper
Abiraterone inhibits CYP17A1 and thus effectively decreases the production of all relevant androgens including DHEAS.
PloS one  •  2016  |  View Paper